Unknown

Dataset Information

0

Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.


ABSTRACT: The strongest genetic influence on immune control in HIV-1 infection is the HLA class I genotype. Rapid disease progression in B-clade infection has been linked to HLA-B*35 expression, in particular to the less common HLA-B*3502 and HLA-B*3503 subtypes but also to the most prevalent subtype, HLA-B*3501. In these studies we first demonstrated that whereas HLA-B*3501 is associated with a high viral set point in two further B-clade-infected cohorts, in Japan and Mexico, this association does not hold in two large C-clade-infected African cohorts. We tested the hypothesis that clade-specific differences in HLA associations with disease outcomes may be related to distinct targeting of critical CD8(+) T-cell epitopes. We observed that only one epitope was significantly targeted differentially, namely, the Gag-specific epitope NPPIPVGDIY (NY10, Gag positions 253 to 262) (P = 2 × 10(-5)). In common with two other HLA-B*3501-restricted epitopes, in Gag and Nef, that were not targeted differentially, a response toward NY10 was associated with a significantly lower viral set point. Nonimmunogenicity of NY10 in B-clade-infected subjects derives from the Gag-D260E polymorphism present in ?90% of B-clade sequences, which critically reduces recognition of the Gag NY10 epitope. These data suggest that in spite of any inherent HLA-linked T-cell receptor repertoire differences that may exist, maximizing the breadth of the Gag-specific CD8(+) T-cell response, by the addition of even a single epitope, may be of overriding importance in achieving immune control of HIV infection. This distinction is of direct relevance to development of vaccines designed to optimize the anti-HIV CD8(+) T-cell response in all individuals, irrespective of HLA type.

SUBMITTER: Matthews PC 

PROVIDER: S-EPMC3497693 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.

Matthews Philippa C PC   Koyanagi Madoka M   Kløverpris Henrik N HN   Harndahl Mikkel M   Stryhn Anette A   Akahoshi Tomohiro T   Gatanaga Hiroyuki H   Oka Shinichi S   Juarez Molina Claudia C   Valenzuela Ponce Humberto H   Avila Rios Santiago S   Cole David D   Carlson Jonathan J   Payne Rebecca P RP   Ogwu Anthony A   Bere Alfred A   Ndung'u Thumbi T   Gounder Kamini K   Chen Fabian F   Riddell Lynn L   Luzzi Graz G   Shapiro Roger R   Brander Christian C   Walker Bruce B   Sewell Andrew K AK   Reyes Teran Gustavo G   Heckerman David D   Hunter Eric E   Buus Søren S   Takiguchi Masafumi M   Goulder Philip J R PJ  

Journal of virology 20120912 23


The strongest genetic influence on immune control in HIV-1 infection is the HLA class I genotype. Rapid disease progression in B-clade infection has been linked to HLA-B*35 expression, in particular to the less common HLA-B*3502 and HLA-B*3503 subtypes but also to the most prevalent subtype, HLA-B*3501. In these studies we first demonstrated that whereas HLA-B*3501 is associated with a high viral set point in two further B-clade-infected cohorts, in Japan and Mexico, this association does not ho  ...[more]

Similar Datasets

| S-EPMC3993828 | biostudies-literature
| S-EPMC3255844 | biostudies-other
| S-EPMC3256563 | biostudies-literature
| S-EPMC5520415 | biostudies-literature
| S-EPMC4043486 | biostudies-literature
| S-EPMC2797323 | biostudies-literature
| S-EPMC3161737 | biostudies-literature
| S-EPMC4363590 | biostudies-literature
| S-EPMC1891314 | biostudies-literature
| S-EPMC2553686 | biostudies-literature